These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 25295482)

  • 1. Platelets: still a therapeutical target for haemostatic disorders.
    Geraldo RB; Sathler PC; Lourenço AL; Saito MS; Cabral LM; Rampelotto PH; Castro HC
    Int J Mol Sci; 2014 Oct; 15(10):17901-19. PubMed ID: 25295482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of endothelium-derived mediators to the efficacy of dual anti-platelet therapy.
    Warner TD; Armstrong PC; Chan MV; Knowles RB
    Expert Rev Hematol; 2016 Mar; 9(3):223-5. PubMed ID: 26822235
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet function and pharmacologic inhibition.
    Chaer RA; Graham JA; Mureebe L
    Vasc Endovascular Surg; 2006; 40(4):261-7. PubMed ID: 16959718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aspirin resistance: position paper of the working group on aspirin resistance of the international society on thrombosis and haemostasis].
    Boskholov BP
    Kardiologiia; 2005; 45(7):75-6. PubMed ID: 16091668
    [No Abstract]   [Full Text] [Related]  

  • 5. New thoughts on strategies for modulating platelet function through the inhibition of surface receptors.
    Nurden AT
    Haemostasis; 1996 Oct; 26 Suppl 4():78-88. PubMed ID: 8979114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
    Lages B; Weiss HJ
    Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Platelets and arterial thrombosis].
    Cazenave JP; Gachet C; Lanza F; Wiesel ML
    Bull Acad Natl Med; 2003; 187(1):35-44; discussion 45-6. PubMed ID: 14556452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelets and lipoprotein(a) in retinal vein occlusion: mutual targets for aspirin therapy.
    Lippi G; Franchini M; Targher G
    Thromb Haemost; 2007 Jun; 97(6):1059-60. PubMed ID: 17549315
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to antiplatelet resistance is it justified?
    Steinhubl SR; Charnigo R; Moliterno DJ
    J Am Coll Cardiol; 2005 Jun; 45(11):1757-8. PubMed ID: 15936601
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
    Santilli F; Lapenna D; La Barba S; Davì G
    Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the glycoprotein IIb/IIIa antagonist abciximab on thrombus formation and platelet function in cats with arterial injury.
    Bright JM; Dowers K; Powers BE
    Vet Ther; 2003; 4(1):35-46. PubMed ID: 12756634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of aspirin-induced decrease in thrombin formation in subjects resistant to aspirin.
    Undas A; Placzkiewicz-Jankowska E; Zieliński L; Tracz W
    Thromb Haemost; 2007 Jun; 97(6):1056-8. PubMed ID: 17549314
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelets and stroke.
    Smith NM; Pathansali R; Bath PM
    Vasc Med; 1999; 4(3):165-72. PubMed ID: 10512596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution of platelet-directed pharmacotherapy.
    Becker RC; Smyth S
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():266-71. PubMed ID: 19630814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
    Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
    Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.